ATBECHDEDKESFR..GRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNO....SM..................*JDIM360 Ver 2.41 (21 Oct 2013) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification2467724CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120141029W184deBibliographieenBibliographyfrBibliographieEP10747657.4201008192012031520130307enenen091453520090819GB20100107920100122GB2014102920144420120627201226201407232014302014020620141029201444G01N 33/68 20060101AFI20110307BHEP deÜBERLEBENSPROGNOSETESTenSURVIVAL PROGNOSTIC ASSAYfrDOSAGE PRONOSTIQUE DE DÉTERMINATION DE LA SURVIEEP-A1- 0 044 219EP-A1- 0 336 472WO-A1-2005/103717WO-A1-2006/079816WO-A1-2007/125338WO-A2-2010/049672DE-U1-202004 012 479GB-B- 2 472 518LE BRICON THIERRY ET AL: "Urinary free light chain analysis by the Freelite(R) immunoassay: A preliminary study in multiple myeloma" CLINICAL BIOCHEMISTRY, ELSEVIER INC, US, CA, vol. 35, no. 7, 1 October 2002 (2002-10-01), pages 565-567, XP008127742 ISSN: 0009-9120RAJKUMAR S VINCENT ET AL: "Presence of monoclonal free light chains in serum predicts risk of progression in monoclonal gammopathy of undetermined significance (MGUS)" BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 102, no. 11, 16 November 2003 (2003-11-16), page 935A, XP008127772 ISSN: 0006-4971STAGGS BRENT ET AL: "Comparison of serum quantitative free light chains (Freelite) to serum quantitative total light chains in recurrent multiple myeloma" ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, COLLEGE OF AMERICAN PATHOLOGISTS, US, vol. 128, no. 2, 1 February 2004 (2004-02-01), page 143, XP008127760 ISSN: 0363-0153SHOWELL P J ET AL: "Correlation of FREELITE (TM) and cystatin C in chronic kidney disease on the binding site SPAPLUS (TM) bench-top analyser" CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, vol. 53, no. 6 sup.S, 1 June 2007 (2007-06-01), page A129, XP008127771 ISSN: 0009-9147HUTCHISON COLIN A ET AL: "Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?" EXPERT OPINION ON THERAPEUTIC TARGETS JUN 2008 LNKD- PUBMED:18479214, vol. 12, no. 6, June 2008 (2008-06), pages 667-676, XP8132516 ISSN: 1744-7631HOFMANN W ET AL: "A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy" CLINICAL LABORATORY, CLIN LAB PUBLICATIONS, HEIDELBERG, vol. 50, no. 3-4, 1 January 2004 (2004-01-01), pages 181-185, XP008132515 ISSN: 1433-6510KYRTSONIS MARIE-CHRISTINE ET AL: "Serum free light chain ratio (FLCR) at diagnosis constitute a powerful prognostic factor of survival in multiple myeloma (MM)" BLOOD; 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO,FL, USA; DECEMBER 09 -12, 2006, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 108, no. 11 part 1, 16 November 2006 (2006-11-16), pages 1-3, XP008132501 ISSN: 0006-4971ROSSI JEAN-FRANCOIS ET AL: "A phase I/II study of atacicept (TACI-Ig) to neutralize APRIL and BLyS in patients with refractory or relapsed multiple myeloma (MM) or active previously treated waldenstrom's macroglobulinemia (WM)" BLOOD; 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO,FL, USA; DECEMBER 09 -12, 2006, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 108, no. 11 part 1, 16 November 2006 (2006-11-16), pages 1-3, XP008132499 ISSN: 0006-4971KATZMANN JERRY A ET AL: "Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains" CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, vol. 48, no. 9, 1 September 2002 (2002-09-01), pages 1437-1444, XP002378160 ISSN: 0009-9147ABADIE JUDE M ET AL: "Are Renal Reference Intervals Required When Screening for Plasma Cell Disorders With Serum Free Light Chains and Serum Protein Electrophoresis?" AMERICAN JOURNAL OF CLINICAL PATHOLOGY, AMERICAN SOCIETY FOR CLINICAL PATHOLOGY, US, vol. 131, no. 2, 1 February 2009 (2009-02-01), pages 166-171, XP008132506 ISSN: 0002-9173 DOI: DOI:10.1309/AJCPR2M4EUYNHLGMGERTZ MORIE A ET AL: "Hepatic amyloidosis: Clinical appraisal in 77 patients" HEPATOLOGY, WILLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 25, no. 1, 1 January 1997 (1997-01-01), pages 118-121, XP008132523 ISSN: 0270-9139 DOI: DOI:10.1002/HEP.510250122 [retrieved on 2003-12-30]BRUCK P ET AL: "Lambda- and kappa-free light chains in haematologic patients" CLINICAL AND EXPERIMENTAL MEDICAL LETTERS,, vol. 49, no. 1, 1 January 2008 (2008-01-01), pages 19-22, XP008132487 ISSN: 1895-2089HOPPER J E ET AL: "CLINICAL RELAPSE IN SYSTEMIC LUPUS ERYTHEMATOSUS CORRELATION WITH ANTECEDENT ELEVATION OF URINARY FREE LIGHT-CHAIN IMMUNOGLOBULIN", JOURNAL OF CLINICAL IMMUNOLOGY, vol. 9, no. 4, 1989, pages 338-350, ISSN: 0271-9142JEFFERIS R ET AL: "QUANTITATION OF HUMAN TOTAL IMMUNO GLOBULIN G KAPPA IMMUNO GLOBULIN G AND LAMBDA IMMUNO GLOBULIN G IN SERUM USING MONO CLONAL ANTIBODIES", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 39, no. 4, 1980, pages 355-362, ISSN: 0022-1759ABE M ET AL: "Differences in kappa to lambda (kappa:gamma) ratios of serum and urinary free light chains", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, vol. 111, no. 2, February 1998 (1998-02), pages 457-462, ISSN: 0009-9104RICOTTA, D. ET AL.: "Serum Free Light Chains in Plasmacell Dyscrasias: Comparison of 2 assays", XI INTERNATIONAL MYELOMA CONFERENCE, 25 June 2007 (2007-06-25), - 30 June 2007 (2007-06-30),ANONYMOUS: 'Freelite TM', [Online] Retrieved from the Internet: <URL:http://www.bindingsite.com/freelite> [retrieved on 2011-03-10]RAJKUMAR S VINCENT ET AL: "Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance", BLOOD, vol. 106, no. 3, August 2005 (2005-08), pages 812-817,803, ISSN: 0006-497114171848.620140610MEAD, Graham PeterP O Box 11712Birmingham B14 4ZBGBBRADWELL, Arthur RandallP O Box 11712Birmingham B14 4ZBGBThe Binding Site Group Limited101134183P333719EP-PCTPO Box 11712Birmingham B14 4ZBGBElsy, Davidet al100046486Withers & Rogers LLP 4 More London RiversideLondon SE1 2AUGBALATBEBGCHCYCZDEDKEEESFIFRGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTROSESISKSMTRGB201005137320100819enWO201102104120110224201108